Physician profile
Olivia Tran
NPI 1649779109
$1,503.44
in general payments reported to CMS, 2019-2025
17 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.84 · 2022: $60.72 · 2023: $398 · 2024: $643 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,409.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $202.75 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.62 | 2021-2025 | Jardiance |
| Abbvie INC. | $173.15 | 2021-2023 | |
| Lilly USA, LLC | $148.94 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Dexcom, INC. | $131.03 | 2023-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $101.24 | 2023-2025 | Gvoke Hypopen |
| Amgen INC. | $95.40 | 2024-2025 | Repatha, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $85.72 | 2023-2025 | |
| Abbott Laboratories | $74.83 | 2024-2025 | Freestyle Libre 3 |
| Madrigal Pharmaceuticals | $64.58 | 2025 | Rezdiffra |
| Esperion Therapeutics, INC. | $60.64 | 2024-2025 | Nexletol |
| Antares Pharma, INC. | $46.72 | 2024 | Xyosted |
| Corcept Therapeutics | $29.12 | 2025 | Korlym |
| Biogen, INC. | $28.42 | 2025 | Skyclarys |
| Pfizer INC. | $22.96 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $22.07 | 2024 | |
| Cequr Corporation | $18.25 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.